Business
Picard to Showcase its Total Artificial Heart at the Annual Meeting of the American Heart Association 2025
TUCSON, Ariz., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and Canadian commercially-approved total artificial heart, today announced it will exhibit at the annual meeting of the American Heart Association (AHA) being held November 7th through 10th in New Orleans, Louisiana. At the annual meeting of the AHA, Picard will showcase its SynCardia™ Total Artificial Hea
About this update from Picard Medical, Inc.
[{"type":"image","alt":"Picard Medical, Inc.","displaySize":"","headline":null,"caption":"Picard Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":266,"url":"https://media.zenfs.com/en/globenewswire.com/7aed5ca33d8d3f4fa4e291322577bb8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GgCsyHKApDgH7PlfNRrYtw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM3MjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7aed5ca33d8d3f4fa4e291322577bb8f","width":300,"height":266}},"lazy":false},{"type":"text","content":"TUCSON, Ariz., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and Canadian commercially-approved total artificial heart, today announced it will exhibit at the annual meeting of the American Heart Association (AHA) being held November 7th through 10th in New Orleans, Louisiana. At the annual meeting of the AHA, Picard will showcase its SynCardia™ Total Artificial Heart (or “STAH”), which is the most widely used and extensively studied artificial heart in the world, at booth #3408.","length":616,"tagName":"p"},{"type":"text","content":"Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical, Inc. commented, “We are excited to attend the annual meeting of the American Heart Association to share the latest developments related to our innovative and life-saving artificial heart, the Syncardia Total Artificial Heart, or STAH. We look forward to having discussions with physicians and attendees at AHA about patient eligibility, the latest clinical data and helpful resources, and sharing insights from patients who have had real-world experiences with the STAH.”","length":540,"tagName":"p"},{"type":"text","content":"About the American Heart Association (AHA) and its Annual Meeting","length":65,"tagName":"p"},{"type":"text","content":"#AHA25 brings together the full spectrum of cardiovascular science—from foundational science and translational breakthroughs to clinical trials and real-world application.","length":171,"tagName":"p"},{"type":"text","content":"Each year, thousands of professionals come together to exchange ideas, build lasting collaborations, and accelerate progress in cardiovascular health on a global scale.","length":168,"tagName":"p"},{"type":"text","content":...